Bright Minds Biosciences (DRUG) Other Operating Expenses (2024 - 2026)

Bright Minds Biosciences' Other Operating Expenses history runs 3 years deep, the most recent figure standing at -$19.6 million for Q1 2026.

• Quarterly Other Operating Expenses fell 5425.29% year-over-year to -$19.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$23.2 million (down 6913.25% YoY) and the FY2025 annual result came in at $1.4 million, up 34.27% from the prior year.
• Other Operating Expenses was -$19.6 million for Q1 2026 at Bright Minds Biosciences, down from -$10.3 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $13.1 million in Q3 2025 and bottomed at -$19.6 million in Q1 2026.
• A 3-year average of -$2.4 million and a median of $230888.4 in 2024 frame the typical range for Other Operating Expenses.
• Annual changes were most pronounced in 2025 — Other Operating Expenses jumped 5593.72% — and 2026, when it tumbled 5425.29%.
• Bright Minds Biosciences' Other Operating Expenses stood at -$771430.5 in 2024, then slumped by 1238.16% to -$10.3 million in 2025, then plunged by 90.34% to -$19.6 million in 2026.
• Business Quant data shows DRUG's Other Operating Expenses at -$19.6 million in Q1 2026, -$10.3 million in Q4 2025, and $13.1 million in Q3 2025.